Auro-Sunitinib 12.5 mg

AURO-SUNITINIB 12.5 MG capsules are a pharmaceutical product containing Sunitinib Malate, used for various therapeutic purposes. This medication is manufactured by AURO PHARMA INC in Canada and is available in an oral capsule form.

AURO-SUNITINIB 12.5 MG capsules are generally used in the treatment of certain types of cancer. Sunitinib Malate, the active ingredient, is often prescribed for its anti-cancer properties. The medication works by targeting specific proteins in the body to help slow or stop the growth of cancer cells. Patients should consult their healthcare provider to understand what Sunitinib is used for in their specific case.

Common effects of AURO-SUNITINIB 12.5 MG capsules may include fatigue, nausea, and diarrhea. Some users might experience skin discoloration or changes in hair color. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects. Always discuss any concerns with a healthcare professional.

Handling AURO-SUNITINIB 12.5 MG capsules requires careful consideration of potential allergies to Sunitinib Malate or any other ingredients. Pregnant or breastfeeding individuals should exercise caution and consult a healthcare provider before use. Store the medication as directed and keep it out of reach of children.

AURO-SUNITINIB 12.5 MG capsules may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.